LONDON, April 10 (Reuters) - GW Pharmaceuticals PLC : * Cannabinoid-medicine sativex moved to schedule 4 of UK drugs act * Pharma - new scheduling means drug can be prescribed with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results